142 related articles for article (PubMed ID: 31020269)
21. Targeted therapy in
Nannini M; Rizzo A; Indio V; Schipani A; Astolfi A; Pantaleo MA
Ther Adv Med Oncol; 2021; 13():17588359211023278. PubMed ID: 34262616
[TBL] [Abstract][Full Text] [Related]
22. O6-Methylguanine DNA Methyltransferase Status Does Not Predict Response or Resistance to Alkylating Agents in Well-Differentiated Pancreatic Neuroendocrine Tumors.
Raj N; Klimstra DS; Horvat N; Zhang L; Chou JF; Capanu M; Basturk O; Do RKG; Allen PJ; Reidy-Lagunes D
Pancreas; 2017 Jul; 46(6):758-763. PubMed ID: 28609363
[TBL] [Abstract][Full Text] [Related]
23. Genotyping and immunohistochemistry of gastrointestinal stromal tumors: An update.
Rubin BP; Heinrich MC
Semin Diagn Pathol; 2015 Sep; 32(5):392-9. PubMed ID: 25766843
[TBL] [Abstract][Full Text] [Related]
24. Succinate Dehydrogenase-Deficient Gastrointestinal Stromal Tumor With SDHC Germline Mutation and Bilateral Renal and Neck Cysts.
Stanley K; Friehling E; Davis A; Ranganathan S
Pediatr Dev Pathol; 2019; 22(3):265-268. PubMed ID: 30301441
[TBL] [Abstract][Full Text] [Related]
25. Succinate Dehydrogenase-Deficient Gastrointestinal Stromal Tumors.
Ibrahim A; Chopra S
Arch Pathol Lab Med; 2020 May; 144(5):655-660. PubMed ID: 31169996
[TBL] [Abstract][Full Text] [Related]
26. [Wild-type gastroinestinal stromal tumors].
Djerouni M; Dumont SN
Bull Cancer; 2020 Apr; 107(4):499-505. PubMed ID: 32063345
[TBL] [Abstract][Full Text] [Related]
27. Succinate dehydrogenase-deficient gastrointestinal stromal tumor: from diagnostic dilemma to novel personalised therapy in 2 case reports.
De Silva M; Rastogi S; Chan D; Angel C; Prall O; Gill A; Guminski A
Transl Cancer Res; 2021 Jul; 10(7):3588-3599. PubMed ID: 35116662
[TBL] [Abstract][Full Text] [Related]
28. Glycogen synthase kinase 3β inhibition sensitizes human glioblastoma cells to temozolomide by affecting O6-methylguanine DNA methyltransferase promoter methylation via c-Myc signaling.
Pyko IV; Nakada M; Sabit H; Teng L; Furuyama N; Hayashi Y; Kawakami K; Minamoto T; Fedulau AS; Hamada J
Carcinogenesis; 2013 Oct; 34(10):2206-17. PubMed ID: 23715499
[TBL] [Abstract][Full Text] [Related]
29. "Wild type" GIST: Clinicopathological features and clinical practice.
Wada R; Arai H; Kure S; Peng WX; Naito Z
Pathol Int; 2016 Aug; 66(8):431-7. PubMed ID: 27427238
[TBL] [Abstract][Full Text] [Related]
30. The progressive fragmentation of the KIT/PDGFRA wild-type (WT) gastrointestinal stromal tumors (GIST).
Nannini M; Urbini M; Astolfi A; Biasco G; Pantaleo MA
J Transl Med; 2017 May; 15(1):113. PubMed ID: 28535771
[TBL] [Abstract][Full Text] [Related]
31. An unusual paraesophageal and diaphragmatic SDHA-deficient gastrointestinal stromal tumor (GIST) metastases case report.
Teke ME; Choi A; Sarvestani AL; Blakely AM; Carr SR
J Gastrointest Oncol; 2023 Feb; 14(1):429-434. PubMed ID: 36915446
[TBL] [Abstract][Full Text] [Related]
32. Gastrointestinal stromal tumours: from KIT to succinate dehydrogenase.
Doyle LA; Hornick JL
Histopathology; 2014 Jan; 64(1):53-67. PubMed ID: 24117705
[TBL] [Abstract][Full Text] [Related]
33. [Detection of O6-methylguanine-DNA methyltransferase promoter methylation in chemotherapy for glioma].
Zheng CQ; Ji SP; Gong F; Li AM; Tai JL; Zhang YP
Ai Zheng; 2009 Jun; 28(6):575-80. PubMed ID: 19635193
[TBL] [Abstract][Full Text] [Related]
34. Genetics of Gastrointestinal Stromal Tumors: A Heterogeneous Family of Tumors?
Patil DT; Rubin BP
Surg Pathol Clin; 2015 Sep; 8(3):515-24. PubMed ID: 26297068
[TBL] [Abstract][Full Text] [Related]
35. Succinate dehydrogenase (SDH)-deficient neoplasia.
Gill AJ
Histopathology; 2018 Jan; 72(1):106-116. PubMed ID: 29239034
[TBL] [Abstract][Full Text] [Related]
36. Classification of gastrointestinal stromal tumor syndromes.
Gopie P; Mei L; Faber AC; Grossman SR; Smith SC; Boikos SA
Endocr Relat Cancer; 2018 Feb; 25(2):R49-R58. PubMed ID: 29170162
[TBL] [Abstract][Full Text] [Related]
37. Dedifferentiation in SDH-Deficient Gastrointestinal Stromal Tumor: A Report With Histologic, Immunophenotypic, and Molecular Characterization.
Malik F; Santiago T; Bahrami A; Davis E; McCarville B; Newman S; Azzato EM; Davidoff AM; Brennan R; Ellison DW; Clay MR
Pediatr Dev Pathol; 2019 Oct; 22(5):492-498. PubMed ID: 31072206
[TBL] [Abstract][Full Text] [Related]
38. S-alkylthiolation of O6-methylguanine-DNA-methyltransferase (MGMT) to sensitize cancer cells to anticancer therapy.
Juillerat A; Juillerat-Jeanneret L
Expert Opin Ther Targets; 2007 Mar; 11(3):349-61. PubMed ID: 17298293
[TBL] [Abstract][Full Text] [Related]
39. Classification of KIT/PDGFRA wild-type gastrointestinal stromal tumors: implications for therapy.
Huss S; Elges S; Trautmann M; Sperveslage J; Hartmann W; Wardelmann E
Expert Rev Anticancer Ther; 2015 Jun; 15(6):623-8. PubMed ID: 25831232
[TBL] [Abstract][Full Text] [Related]
40. Integrating miRNA and gene expression profiling analysis revealed regulatory networks in gastrointestinal stromal tumors.
Pantaleo MA; Ravegnini G; Astolfi A; Simeon V; Nannini M; Saponara M; Urbini M; Gatto L; Indio V; Sammarini G; Santini D; Ferracin M; Negrini M; Hrelia P; Biasco G; Angelini S
Epigenomics; 2016 Oct; 8(10):1347-1366. PubMed ID: 27625077
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
